13F Holdings
中文EN

NUS NU SKIN ENTERPRISES, INC.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 1021561 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-15.3%
TTM net income YoY-313.7%
TTM EPS YoY-321.9%
Revenue 3-yr CAGR-12.9%
Net income 3-yr CAGR—

Margins

Gross margin67.8%
Operating margin-2.0%
Net margin-17.7%
FCF margin-2.0%
EBITDA margin1.8%

Returns

ROE-34.8%
ROA-18.6%
ROIC (approx.)-3.1%
Asset turnover1.05x

Leverage & solvency

Liabilities / assets49.7%
Debt / equity0.37x
Current ratio2.04x
Interest coverage-1.79x

Cash quality & payout

Operating cash flow / net income-0.06x
Accruals ratio-19.9%
Payout ratio—
Capex / revenue3.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.49B$1.73B$1.97B$2.23B$2.70B
Cost of revenue$453.76M$550.23M$611.85M$630.91M$675.22M
Gross profit$1.03B$1.18B$1.36B$1.59B$2.02B
R&D expense$10.80M$13.00M$22.60M$23.30M$27.20M
SG&A expense$432.14M$479.04M$546.86M$555.77M$654.43M
Operating income$65.76M-$151.59M$48.27M$110.85M$233.99M
Interest expense$13.95M$26.41M$25.56M$13.49M$11.00M
Pretax income$196.20M-$175.05M$26.58M$88.97M$232.46M
Income tax$35.99M-$28.46M$17.98M-$15.81M$85.19M
Net income$160.20M-$146.59M$8.60M$104.78M$147.27M
EBITDA$118.02M-$81.78M$119.19M$183.35M$310.31M
EPS (basic)3.25-2.950.172.102.93
EPS (diluted)3.18-2.950.172.072.86
Weighted avg. shares (diluted)50.30M49.66M49.86M50.52M51.43M
Balance sheet
Cash & equivalents$238.63M$186.88M$256.06M$264.73M$339.59M
Short-term investments$1.21M$11.11M$11.76M$13.78M$15.22M
Receivables$39.54M$50.78M$58.70M$47.36M$41.30M
Inventory$178.64M$190.24M$279.98M$346.18M$399.93M
Current assets$547.70M$538.60M$701.87M$759.87M$872.95M
PP&E, net$377.17M$379.60M$432.96M$444.81M$453.67M
Goodwill$83.62M$83.62M$218.17M$206.43M$206.43M
Intangibles$42.61M$74.28M$95.26M$66.70M$76.99M
Total assets$1.41B$1.47B$1.81B$1.82B$1.91B
Current liabilities$263.73M$296.61M$328.87M$359.24M$529.69M
Short-term debt$20.00M$30.00M$25.00M$25.00M$107.50M
Long-term debt$204.19M$363.61M$478.04M$377.47M$268.78M
Total debt$224.19M$393.61M$503.04M$402.47M$376.28M
Total liabilities$600.07M$817.46M$986.66M$923.67M$993.71M
Shareholders' equity$805.24M$651.46M$821.97M$897.30M$912.77M
Net debt-$14.44M$206.73M$246.98M$137.74M$36.69M
Cash flow statement
Operating cash flow$80.29M$111.74M$118.64M$108.06M$141.58M
Capital expenditure$34.28M$41.58M$58.49M$59.06M$68.61M
Free cash flow$46.01M$70.16M$60.15M$49.01M$72.97M
Investing cash flow$170.66M-$37.96M-$134.50M-$67.08M-$88.73M
Financing cash flow-$202.40M-$133.18M$10.73M-$99.50M-$104.70M
Depreciation & amortization$52.26M$69.81M$70.92M$72.51M$76.32M
Stock-based compensation$24.11M$14.82M$15.65M$12.37M$23.19M
Dividends paid$11.83M$11.93M$77.62M$77.02M$76.27M
Share buybacks$20.04M$0$13.01M$70.05M$80.42M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.